{"entity":{"id":"peter-mac","kind":"institution","name":"Peter MacCallum Cancer Centre","aka":[],"tldr":"Peter Mac is Australia's only dedicated cancer hospital and a leader in theranostics, CAR-T, and radiation oncology.","summary":"Peter MacCallum Cancer Centre in Melbourne is Australia's only dedicated cancer hospital, the core of the Victorian Comprehensive Cancer Centre, and ranks fourteenth in the Newsweek/Statista oncology list. It pioneered PSMA PET imaging and lutetium-177 PSMA radioligand therapy through Hofman's TheraP and proPSMA trials, became Australia's first CAR-T centre, and has a strong radiation oncology programme, with Sarah-Jane Dawson, Joseph Trapani, Declan G. Murphy, Andrew H. Wei and Grant McArthur among its people. Nuclide links it to prostate cancer, to the CROWN and DYNAMIC papers, to ANZUP and other Australian trial groups, and to ideas for a rapid research autopsy network and a shared cyclotron network for new tracers. Getting radioligand supply and regulation to match demand is the open problem its theranostics work exposes. Its trial and people pages carry the detail.","asOf":"2026-09-04","wikipedia":"https://en.wikipedia.org/wiki/Peter_MacCallum_Cancer_Centre","links":[{"label":"Official website","url":"https://www.petermac.org"}],"tags":[],"related":["lu-177"],"indications":[],"sections":[],"technologies":["psma-pet","radioligand-therapy"],"targets":[],"drugs":["pluvicto"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":["declan-murphy","hofman-michael","sandhu-shahneen"],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Melbourne","country":"AU","lat":-37.799,"lng":144.956,"institutionType":"cancer-center","website":"https://www.petermac.org","newsweekOncology2026":14,"programs":["PSMA theranostics (TheraP, proPSMA)","CAR-T","Radiation oncology"]},"route":"/institutions/peter-mac/","neighbours":{"isotope":[{"id":"lu-177","kind":"isotope","name":"Lutetium-177","route":"/isotopes/lu-177/"}],"technology":[{"id":"psma-pet","kind":"technology","name":"PSMA PET","route":"/technologies/psma-pet/"},{"id":"radioligand-therapy","kind":"technology","name":"Radioligand therapy (beta emitters)","route":"/technologies/radioligand-therapy/"}],"drug":[{"id":"pluvicto","kind":"drug","name":"Lutetium-177 vipivotide tetraxetan","route":"/drugs/pluvicto/"}],"person":[{"id":"declan-murphy","kind":"person","name":"Declan G. Murphy","route":"/people/declan-murphy/"},{"id":"hofman-michael","kind":"person","name":"Michael Hofman","route":"/people/hofman-michael/"},{"id":"rodney-hicks","kind":"person","name":"Rodney J. Hicks","route":"/people/rodney-hicks/"},{"id":"sandhu-shahneen","kind":"person","name":"Shahneen Sandhu","route":"/people/sandhu-shahneen/"}],"indication":[{"id":"prostate","kind":"indication","name":"Prostate cancer","route":"/indications/prostate/"}],"institution":[{"id":"anzup","kind":"institution","name":"ANZUP Cancer Trials Group","route":"/institutions/anzup/"}],"trial":[{"id":"propsma","kind":"trial","name":"proPSMA","route":"/trials/propsma/"},{"id":"therap","kind":"trial","name":"TheraP (ANZUP 1603)","route":"/trials/therap/"}],"idea":[{"id":"idea-fund-academic-radiopharma-pipeline","kind":"idea","name":"A university cyclotron network with shared regulatory files for new tracers","route":"/ideas/idea-fund-academic-radiopharma-pipeline/"}]}}